Task: Answer the multiple choice question.
Query: Which compound exhibits a 16.236\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) COC(=O)C1=CN(CC2CCCO2)C=C(C(=O)OC)C1c1cc(OC)c(OC)c(OC)c1
(b) CSc1ncccc1C(=O)Nc1cccc(S(=O)(=O)N2CCCCC2)c1
(c) C/C(Cn1ncc(N2CCOCC2)c(Cl)c1=O)=N\O
Answer: c. C/C(Cn1ncc(N2CCOCC2)c(Cl)c1=O)=N\O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(Cn1ncc(N2CCOCC2)c(Cl)c1=O)=N\O
C/C(Cn1ncc(N2CCOCC2)c(Cl)c1=O)=N\O
4-chloro-2-[(2E)-2-hydroxyiminopropyl]-5-morpholin-4-ylpyridazin-3-one